Acrux Ltd
Company Profile
Business description
Acrux Ltd is a pharmaceutical company dedicated to developing and commercializing generic transdermal and topical prescription pharmaceuticals. The group is formulating and developing a range of topical generic products by leveraging its skilled workforce, on-site laboratories, GMP manufacturing suite, and technical, clinical, and commercial experience to bring affordable products to market. Geographically, it has a presence in Australia; the United States; Europe, and other countries. The firm operates in a single segment and derives revenue from developing and commercializing pharmaceutical products that administer drugs topically. Its product pipeline products include Lenzetto, Evamist, Testosterone Topical Solution, and among others.
Contact
103-113 Stanley Street
West Melbourne
MelbourneVIC3003
AUST: +61 383790100
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
30 June 2025
Employees
36
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,715.80 | 25.60 | -0.29% |
CAC 40 | 7,553.45 | 102.67 | -1.34% |
DAX 40 | 23,057.38 | 260.43 | -1.12% |
Dow JONES (US) | 42,171.66 | 44.14 | -0.10% |
FTSE 100 | 8,791.80 | 51.67 | -0.58% |
HKSE | 23,474.81 | 237.07 | 1.02% |
NASDAQ | 19,546.27 | 25.18 | 0.13% |
Nikkei 225 | 38,480.86 | 7.48 | -0.02% |
NZX 50 Index | 12,569.05 | 58.27 | -0.46% |
S&P 500 | 5,980.87 | 1.85 | -0.03% |
S&P/ASX 200 | 8,496.40 | 27.30 | -0.32% |
SSE Composite Index | 3,364.83 | 2.73 | 0.08% |